Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Biotalys NVFRA:86C -5.78%25 Equity-to-Asset is 0.66 as of Jun. 2026, which is 7% below its 10-year median of 0.71. GuruFocus rates FRA:86C with a GF Score™ of 25/100. The stock has 1 warning sign investors should review. Among 261 Agriculture companies, Biotalys NV ranks better than 74.71% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Biotalys NV's Total Stockholders Equity for the quarter that ended in Jun. 2026 was €14.97 Mil. Biotalys NV's Total Assets for the quarter that ended in Jun. 2026 was €22.60 Mil.
The historical rank and industry rank for Biotalys NV's Equity-to-Asset or its related term are showing as below:
FRA:86C'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.2 Med: 0.71 Max: 0.84
Current: 0.66
During the past 8 years, the highest Equity to Asset Ratio of Biotalys NV was 0.84. The lowest was 0.20. And the median was 0.71.
FRA:86C's Equity-to-Asset is ranked better than 74.71% of 261
companies
in the Agriculture industry
Industry Median: 0.53
vs FRA:86C: 0.66
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Biotalys NV Equity-to-Asset Related Terms
Biotalys NV Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Biotalys NV's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:86C vs CTVA, CF, MOS: Equity-to-Asset Comparison
For the Agricultural Inputs subindustry, Biotalys NV's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biotalys NV Equity-to-Asset vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Biotalys NV's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Biotalys NV's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Biotalys NV's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biotalys NV (FRA:86C) has a Equity-to-Asset of 0.66 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Biotalys NV and its competitors. This is near median its historical median of 0.71. Over the past decade, Biotalys NV's Equity-to-Asset has ranged from 0.20 to 0.84. According to the industry distribution chart, Biotalys NV ranks #66 out of 261 companies in the Agriculture industry, placing it in the top 25.3%.
Is Biotalys NV's Equity-to-Asset too high?
Biotalys NV's current Equity-to-Asset of 0.66 is near median its 10-year median of 0.71. Over the past 10 years, this metric has ranged from a low of 0.20 to a high of 0.84. The Agriculture industry median Equity-to-Asset is 0.53. Biotalys NV's value of 0.66 is 24.5% above this industry median. Based on the distribution chart, Biotalys NV ranks #66 out of 261 companies in the Agriculture industry, which is above the industry midpoint. Overall, Biotalys NV has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Biotalys NV's Equity-to-Asset compare to CTVA and CF?
According to the Agriculture industry distribution chart, Biotalys NV ranks #66 out of 261 companies for Equity-to-Asset. This puts Biotalys NV in the upper half of its industry. The industry median Equity-to-Asset is 0.53. Biotalys NV's value of 0.66 is 24.5% above this benchmark. Historically, Biotalys NV's own Equity-to-Asset has ranged from 0.20 to 0.84 over the past decade. While the company's 10-year median is 0.71 vs. the industry median of 0.53, Biotalys NV has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for an Agriculture company?
The median Equity-to-Asset among Agriculture companies is 0.53, based on 261 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Biotalys NV's current Equity-to-Asset of 0.66 is 24.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Biotalys NV and its competitors. For the Agriculture industry, the median Equity-to-Asset is 0.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Biotalys NV's current Equity-to-Asset is 0.66, which is near median its own 10-year median of 0.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biotalys NV stock overvalued right now?
Biotalys NV (FRA:86C) has a current Equity-to-Asset of 0.66. The current Equity-to-Asset is 0.66, which is near median its 10-year median of 0.71 and 24.5% above the Agriculture industry median of 0.53. Biotalys NV's overall GF Score™ is 25/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Biotalys NV (FRA:86C), the current Equity-to-Asset is 0.66 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Biotalys NV is an Agricultural Technology (AgTech) company developing Precision Biocontrol solutions based on proteins for the protection of crops in both the pre and post harvest markets. The company provides novel solutions that bridge the efficacy and scale of chemistry with the environmental advantages of biological solutions. Its pipeline EVOCA 1st Gen, EVOCA NG, BioFun-6, and BioFun-7. It operates in single segment.
25GF Score
Get the complete analysis for FRA:86C
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:86C has been successfully added to your 
